We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are OK with this.     OK  No, I would like to know more...
Home / About Novasep / Media & Events / Press releases

Press releases

Novasep signs a manufacturing services agreement with Exelixis for a next-generation ADC

Novasep signs a manufacturing services agreement with Exelixis for a next-generation ADC

06 Jul 2021

• The agreement covers the cGMP clinical manufacturing of a next-generation ADC drug candidate
• Novasep’s Le Mans site, in France, has already manufactured the ADC for Exelixis’ ongoing phase 1 clinical trial
• Novasep leverages its ADC bioconjugation expertise and process development capabilities in support of promising new cancer treatments


Novasep invests €6.1 million to upgrade its manufacturing facility for Active Pharmaceutical Ingredients at its Mourenx site

Novasep invests €6.1 million to upgrade its manufacturing facility for Active Pharmaceutical Ingredients at its Mourenx site

24 Jun 2021





• Novasep continues its investment strategy by upgrading its API manufacturing facility at its Mourenx site, increasing its flexibility and competitiveness
• A €6.1 million investment will be made over 3 years
• This investment has been selected by the French Government to be supported by ‘France Relance’, the post-Covid recovery plan
• 7 full-time jobs to be created


Following the repayment in full of its euro-denominated notes due 2022, novasep announces its intent to pay an interim dividend on or around june 30, 2021

Le Campus Biotech Digital s’allie à Atos, IBM et Microsoft pour le développement d’une plateforme de formation unique au monde

Le Campus Biotech Digital s’allie à Atos, IBM et Microsoft pour le développement d’une plateforme de formation unique au monde

27 May 2021

Une nouvelle étape pour l’avancée d’un projet innovant et structurant au service de la Bioproduction de santé française


Novasep expands its HPAPI manufacturing capacity in Le Mans for innovative cancer therapies

Novasep expands its HPAPI manufacturing capacity in Le Mans for innovative cancer therapies

12 May 2021

• Novasep continues to consolidate its position as a leading CDMO for the production of innovative and targeted molecules to treat cancer by investing in additional capacity
• Responds to increasing customer demand for manufacturing services for Antibody Drug Conjugates (ADCs)
• More than 30 full-time jobs to be created


Novasep announces strong growth in 2020, in an exceptional context, demonstrating the robustness of its strategic model

Novasep announces strong growth in 2020, in an exceptional context, demonstrating the robustness of its strategic model

05 May 2021

• The Group recorded sales of €394M (+46%) and an EBITDA of €63M (+174%)
• Novasep has now completed its Rise-2 strategic plan, a full two years ahead of schedule
• Full deleveraging is in progress following the divestment of the Viral Vector Manufacturing Business in early 2021


Novasep announces results of notes offer for its outstanding euro-denominated unsecured exchange notes due 2022

Novasep announces results of notes offer for its outstanding euro-denominated unsecured exchange notes due 2022

29 Apr 2021

Novasep Holding S.A.S. (“Novasep”) has today announced the results of its offer to purchase (the “Notes Offer”) any and all of its outstanding euro-denominated unsecured exchange notes due 2022 (the “Notes”).


Novasep announces notes offer for its outstanding euro-denominated unsecured exchange notes due 2022 and concurrent optional redemption

Novasep announces notes offer for its outstanding euro-denominated unsecured exchange notes due 2022 and concurrent optional redemption

01 Apr 2021

Novasep Holding S.A.S. (“Novasep”) has today commenced an offer to purchase (the “Notes Offer”) any and all of its outstanding euro-denominated unsecured exchange notes due 2022 (the “Notes”).


Le Campus Biotech Digital s’allie aux écoles et organismes de formation en biotechnologie pour développer les talents de demain

Le Campus Biotech Digital s’allie aux écoles et organismes de formation en biotechnologie pour développer les talents de demain

09 Mar 2021

Une alliance inédite au service de la filière de Bioproduction française


NOVASEP and BONUMOSE announce a strategic collaboration for high-purity rare sugars processing scale-up in Virginia, USA

NOVASEP and BONUMOSE announce a strategic collaboration for high-purity rare sugars processing scale-up in Virginia, USA

03 Mar 2021

The collaboration covers the design, engineering and commissioning of a complete process line to produce High Purity Rare Sugars such as Tagatose and Allulose.



You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Your brochure is ready!

X

You can stay on this page and select more documents or you can directly download the brochure(s) you selected

Give us your feedback!